Inventor · disambiguated record
Matthew Robers
Also filed as: ROBERS MATTHEW · ROBERS MATTHEW B
28 granted patents·7 pending applications·244 citations·filing 2006–2024
96Inventor score
Top patents by PatentIndex Score
35 records- 0198US11661623B2Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of usePROMEGA CORP·Filed 2020·Granted May 30, 2023·3 cites·11 claims
- 0298US10107800B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2017·Granted Oct 23, 2018·14 cites·18 claims
- 0398US9797889B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2014·Granted Oct 24, 2017·33 cites·12 claims
- 0498US8669103B2Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of useBINKOWSKI BROCK·Filed 2011·Granted Mar 11, 2014·95 cites·22 claims
- 0597US11493504B2Activation of bioluminescene by structural complementationPROMEGA CORP·Filed 2020·Granted Nov 8, 2022·4 cites·13 claims
- 0697US9797890B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2014·Granted Oct 24, 2017·24 cites·13 claims
- 0796US10648971B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2018·Granted May 12, 2020·6 cites·7 claims
- 0896US10288605B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2018·Granted May 14, 2019·10 cites·18 claims
- 0995US9869670B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2016·Granted Jan 16, 2018·12 cites·25 claims
- 1094US10815247B2Functionalized NANOLUC inhibitorsPROMEGA CORP·Filed 2017·Granted Oct 27, 2020·11 cites·40 claims
- 1194US10774364B2Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of usePROMEGA CORP·Filed 2018·Granted Sep 15, 2020·5 cites·9 claims
- 1294US10184936B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2018·Granted Jan 22, 2019·5 cites·3 claims
- 1394US9951373B2Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of usePROMEGA CORP·Filed 2014·Granted Apr 24, 2018·8 cites·18 claims
- 1493US9840730B2Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of usePROMEGA CORP·Filed 2014·Granted Dec 12, 2017·8 cites·16 claims
- 1592US12366572B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2024·Granted Jul 22, 2025·0 cites·5 claims
- 1692US12215375B2Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of usePROMEGA CORP·Filed 2021·Granted Feb 4, 2025·1 cites·5 claims
- 1791US12435354B2Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of usePROMEGA CORP·Filed 2023·Granted Oct 7, 2025·0 cites·5 claims
- 1889US2025045806A1Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2024·Application pending·0 cites
- 1987US10571471B2Luciferase-based thermal shift assaysPROMEGA CORP·Filed 2016·Granted Feb 25, 2020·2 cites·14 claims
- 2086US12367513B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2022·Granted Jul 22, 2025·0 cites·13 claims
- 2184US11899021B2Luciferase-based thermal shift assaysPROMEGA CORP·Filed 2023·Granted Feb 13, 2024·0 cites·11 claims
- 2280US11442063B2Broad spectrum kinase binding agentsPROMEGA CORP·Filed 2019·Granted Sep 13, 2022·1 cites·20 claims
- 2378US2025188510A1Enhancement of kinase target engagementPROMEGA CORP·Filed 2024·Application pending·0 cites
- 2476US11567083B2Luciferase-based thermal shift assaysPROMEGA CORP·Filed 2020·Granted Jan 31, 2023·0 cites·13 claims
- 2574US12078634B2Broad spectrum kinase binding agentsPROMEGA CORP·Filed 2022·Granted Sep 3, 2024·0 cites·14 claims
- 2673US10928400B2Luciferase-based thermal shift assaysPROMEGA CORP·Filed 2020·Granted Feb 23, 2021·0 cites·9 claims
- 2772US8642256B2Kinase and ubiquination assaysVOGEL KURT·Filed 2009·Granted Feb 4, 2014·1 cites·17 claims
- 2870US9096889B2Compositions and methods for monitoring transmembrane traffickingPROMEGA CORP·Filed 2012·Granted Aug 4, 2015·1 cites·20 claims
- 2965US2021363565A1Enhancement of kinase target engagementPROMEGA CORP·Filed 2021·Application pending·0 cites
- 3061US2020063110A1Thienopyrrole compounds and uses thereofPROMEGA CORP·Filed 2019·Application pending·0 cites
- 3158US10513694B2Thienopyrrole compounds and uses thereofPROMEGA CORP·Filed 2016·Granted Dec 24, 2019·0 cites·25 claims
- 3257US9738921B2Compositions and methods for monitoring transmembrane traffickingPROMEGA CORP·Filed 2015·Granted Aug 22, 2017·0 cites·10 claims
- 3356US2022064696A1Target engagement assay for ras proteinsPROMEGA CORP·Filed 2021·Application pending·0 cites
- 3456US2007264678A1Kinase and ubiquination assaysINVITROGEN CORP·Filed 2006·Application pending·0 cites
- 3549US2008138836A1Kinase and ubiquination assaysINVITROGEN CORP·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Robers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →